HEMEMICS BIOTECHNOLOGIES, INC.

Profile

Company Names

HEMEMICS BIOTECHNOLOGIES, INC.

Addresses

9700 GREAT SENECA HIGHWAY, ROCKVILLE, MD 20850

Phone Numbers

301-560-0415

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$877,473.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2020-12-07 
$100,000.00 
$1,500,000.00 
$1,400,000.00 
Equity 
1
2018-04-07 
$777,473.00 
$2,277,473.00 
$1,500,000.00 
Equity, Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROGER 
S. 
BROOK 
EXECUTIVE OFFICER, DIRECTOR
HEMEMICS BIOTECHNOLOGIES, INC.
BRUCE 
A. 
CAMPBELL 
EXECUTIVE OFFICER, DIRECTOR
HEMEMICS BIOTECHNOLOGIES, INC.
MARIA 
 
FATTORE 
EXECUTIVE OFFICER
HEMEMICS BIOTECHNOLOGIES, INC.
BRANDON 
B. 
HO 
EXECUTIVE OFFICER
HEMEMICS BIOTECHNOLOGIES, INC.
DAVID 
 
HO 
EXECUTIVE OFFICER, DIRECTOR
FIRST PRINCIPLES ABS FUND, LLC   |  FIRST PRINCIPLES TREASURY FUND I LTD   |  FIRST PRINCIPLES STRUCTURED INCOME FUND, LLC   |  FPCM EMERGING MARKETS INFLATION-LINKED SECURITIES FUND LP   |  TRIQUINT SEMICONDUCTOR INC   |  HEMEMICS BIOTECHNOLOGIES, INC.   |  VICARIOUS SURGICAL INC.
DAVID 
H. 
HO 
EXECUTIVE OFFICER, DIRECTOR
HEMEMICS BIOTECHNOLOGIES, INC.
JAMES 
P. 
HOGARTY 
EXECUTIVE OFFICER, DIRECTOR
HEMEMICS BIOTECHNOLOGIES, INC.
HAO 
 
NGUYEN 
DIRECTOR
HEMEMICS BIOTECHNOLOGIES, INC.
HOA 
 
NGUYEN 
DIRECTOR
HEMEMICS BIOTECHNOLOGIES, INC.   |  MDM AT KATY LLC   |  MOMENTUM DEERBROOK LLC   |  GRAYSON AT BAYBROOK MULTIFAMILY FRIENDSWOOD LLC   |  MOMENTUM JONES ROAD LLC   |  FASH CUSTER, LTD.
MARY 
 
SCHMIDT 
DIRECTOR
HEMEMICS BIOTECHNOLOGIES, INC.
LARRY 
 
SIMPSON 
DIRECTOR
HEMEMICS BIOTECHNOLOGIES, INC.
DANN 
 
THOMAS 
DIRECTOR
HEMEMICS BIOTECHNOLOGIES, INC.
JOHN 
 
WARDEN 
EXECUTIVE OFFICER, DIRECTOR
HEMEMICS BIOTECHNOLOGIES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-12-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-07 
2018-05-25
D
Link
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity, Debt 
2018-04-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#